Fibroblasts within the mammary tumor microenvironment are active participants in carcinogenesis mediating both tumor initiation and progression. Our group has previously demonstrated that genetic loss of phosphatase and tensin homolog (PTEN) in mammary fibroblasts induces an oncogenic secretome that remodels the extracellular milieu accelerating ErbB2-driven mammary tumor progression. While these prior studies highlighted a tumor suppressive role for stromal PTEN, how the adjacent normal epithelium transforms in response to PTEN loss was not previously addressed. To identify these early events, we have evaluated both phenotypic and genetic changes within the pre-neoplastic mammary epithelium of mice with and without stromal PTEN expression. We report that fibroblast-specific PTEN deletion greatly restricts mammary ductal elongation and induces aberrant alveolar side-branching. These mice concomitantly exhibit an expansion of the mammary epithelial stem cell (MaSC) enriched basal/myoepithelial population and an increase in in vitro stem cell activity. Further analysis revealed that NOTCH signaling, specifically through NOTCH3, is diminished in these cells. Mechanistically, JAGGED-1, a transmembrane ligand for the NOTCH receptor, is downregulated in the PTEN-null fibroblasts leading to a loss in the paracrine activation of NOTCH signaling from the surrounding stroma. Reintroduction of JAGGED-1 expression within the PTEN-null fibroblasts was sufficient to abrogate the observed increase in colony forming activity implying a direct role for stromal JAGGED-1 in regulation of MaSC properties. Importantly, breast cancer patients whose tumors express both low stromal JAG1 and low stromal PTEN exhibit a shorter time to recurrence than those whose tumors express low levels of either alone suggesting similar stromal signaling in advanced disease. Combined, these results unveil a novel stromal PTEN-to-JAGGED-1 axis in maintaining the MaSC niche, and subsequently inhibiting breast cancer initiation and disease progression.
INTRODUCTION
The tumor microenvironment plays an indispensable role in promoting mammary tumor initiation, progression and metastasis. 1 Fibroblasts maintain tissue homeostasis throughout development by regulating a plethora of processes including extracellular matrix (ECM) deposition, growth factor and chemokine secretion, inflammation and wound healing. 2, 3 In breast cancer, cancer associated fibroblasts are aberrantly activated by largely unidentified mechanisms to engender an environment that favors tumor growth. 4, 5 Despite comprehensive evidence supporting cancer associated fibroblasts in the tumor microenvironment, little is known about the pathways within these cells that fuel tumor growth. Our group demonstrated that genetic ablation of the tumor suppressor phosphatase and tensin homolog (Pten) within the mammary stroma greatly accelerates HER2/Neu (MMTV-ErbB2) driven mammary tumorigenesis. 6, 7 These previous studies were the first to demonstrate that malignant transformation of tumor epithelium can depend on fibroblastspecific signaling. Importantly, decreased stromal PTEN was observed in a subset of breast cancer patients and inversely correlated with stromal pro-oncogenic activated AKT1. 7 Although these studies established a tumor suppressive role for PTEN within the mammary stroma, the mechanisms by which pre-neoplastic epithelia are reprogrammed in response to altered signaling surrounding fibroblasts have not been elucidated.
Mammary gland morphogenesis occurs predominantly postnatally whereby epithelial stem/progenitor cells generate mammary ducts during puberty. [8] [9] [10] [11] [12] [13] Secretory alveoli then arise throughout estrus cycling, and become fully differentiated lobuloalveoli during pregnancy and lactation.
14 This process is highly dynamic and closely mirrors tumorigenesis in that the mammary epithelium proliferates, invades into the fat pad and stimulates angiogenesis in response to surrounding stromal cells, including fibroblasts. 15 Thus, aberrant signaling between stroma and epithelia are likely to cause oncogenic disruptions within specific epithelial subpopulations. In this report, we show that genetic loss of stromal Pten elicits non-cell autonomous changes within associated pre-neoplastic epithelium resulting in stunted mammary ductal elongation and aberrant alveolar side-branching. This phenotype is paralleled by an expansion of the mammary stem cell (MaSC) enriched population. We further demonstrate that ablation of stromal PTEN decreases NOTCH receptor signaling in the associated MaSC-enriched population, and NOTCH3, specifically, is decreased in the basal/myoepithelium upon stromal PTEN deletion. Mechanistically, PTEN-null fibroblasts exhibit significantly decreased JAGGED-1, one of the ligands for the NOTCH receptor, resulting in diminished JAGGED-1/NOTCH3 paracrine signaling, and a subsequent increase in MaSC activity. Importantly, low stromal PTEN and JAG1 correlates with shorter time to recurrence in breast cancer patients implying similar signaling in the tumor microenvironment.
RESULTS
Loss of stromal PTEN restricts mammary ductal elongation and promotes aberrant alveolar side-branching Loss of stromal PTEN accelerates MMTV-ErbB2-driven mammary tumor growth, which occurs at~16-20 weeks of age. 7 Since mammary gland development like tumorigenesis is regulated by the stromal microenvironment, we evaluated early changes in the adjacent epithelium associated with PTEN loss. 9, 15 To this end, we compared pre-neoplastic mammary glands of post-pubertal virgin mice (8-9 weeks of age) in four genetic groups: Pten fl/fl (wild-type epithelium; wild-type stroma), Fsp-cre;Pten fl/fl (wild-type epithelium; PTEN-null stroma), MMTV-ErbB2;Pten fl/fl (ErbB2 epithelium; wild-type stroma) and MMTV-ErbB2;Fsp-cre;Pten fl/fl (ErbB2 epithelium; PTEN-null stroma). Importantly, ablation of stromal PTEN greatly impaired epithelial ductal elongation (Figures 1a and b) and increased alveolar side-branching in the presence or absence of ErbB2 (Figures 1a and c) .
To explore how stromal PTEN alters the mammary epithelium, we analyzed gene expression between gravity prepped epithelium from wild-type versus stromal PTEN-null mice at 8 weeks of age previously published by our group. 16 Unsupervised gene set enrichment analysis querying all the C2 curated genesets within the Molecular Signatures Database (MSigDB) indicated enrichment of an adipose stem cell gene set 17 Figure 1C) . 18 These combined results indicate that ablation of fibroblast PTEN elicits genomic changes within adjacent pre-neoplastic epithelial subpopulations.
Loss of stromal Pten expands the MaSC-enriched population Mammary stem cells exist within the basal/myoepithelium to coordinate ductal expansion and are strictly regulated by stromal cells and ECM components. 13, [19] [20] [21] [22] To determine if loss of fibroblast PTEN alters the mammary epithelial populations, we used well-described fluorescence activated cell sorting markers to evaluate 8-9-week-old control and experimental mice. 23 First, we confirmed our technique using wild-type FVB/N animals with appropriate isotype controls ( Supplementary Figure 2A and Figure 2C) .
Fluorescence activated cell sorting analyses of Pten fl/fl and Fsp-cre;Pten fl/fl mice revealed that mammary glands with PTEN-null stroma exhibited a significant expansion of the MaSC-enriched basal/myoepithelial population (Figure 2a) . Similarly, the MaSCenriched pool was expanded in ErbB2;Fsp-cre;Pten fl/fl mice ( Figure 2c ). In contrast, no significant changes were observed in the Lin − CD24 + CD29 Lo total luminal populations in the absence of stromal PTEN with or without ErbB2 (Figures 2a and c (Figures 2b and d) . To extend this observation of increased MaSC-enriched cells, we assessed in vitro differentiation and stem cell activity. MaSC-enriched cells from ErbB2-positive stromal PTEN-null mammary glands generated significantly more 3D organoids compared to control (Figure 3a) , and these organoids exhibited increased dual cytokeratin-5/cytokeratin-8 positivity demonstrating increased stem-like activity (Figure 3b ). In corroboration, MaSC-enriched cells from fibroblast PTEN-null mice have significantly enhanced colony forming ability in vitro (Figure 3c) , and demonstrate an enhanced ability to form mammospheres under non-adherent culture conditions (Figure 3d ). Importantly, no loss of PTEN was detected in MaSC-enriched cells by indirect immunofluorescent staining (Supplementary Figures 3A and B) . (Figure 4b ). To verify Notch3 specifically drives the signature, the remaining family members (Notch1, Notch2, Notch4) were concluded as unchanged (Supplementary Figure 4C) . Lastly, we confirmed the NOTCH target gene Hes1 was also downregulated supporting diminished NOTCH signaling (Figure 4c ; Supplementary Figure 4B ).
To confirm diminished NOTCH3 protein, we performed immunohistochemistry staining in 8-9-week mammary glands. Discontinuous NOTCH3 staining was observed in the basal/ myoepithelium of stromal PTEN-null mice with or without ErbB2 (Supplementary Figure 5A) . NOTCH3 staining was also observed in the luminal lineage within all the glands, albeit at lower levels, and so to accurately quantify NOTCH3 exclusively in the MaSC-containing basal/myoepithelium, we carried out dual-immunofluorescence for NOTCH3 and alpha-smooth muscle actin (α-SMA), a marker for the basal/myoepithelium (Figures 4d and e) . We measured the percentage of NOTCH3 positive area with respect to α-SMA positive area and found that NOTCH3 was significantly downregulated in the α-SMA positive MaSC-enriched basal/myoepithelium in stromal PTEN-null mammary glands (Figures 4b and d) . Notably, Notch3 mRNA was unchanged in both the luminal progenitor and mature luminal populations (Supplementary Figure 5B) supporting a role for NOTCH3 specifically within the MaSC-enriched cells.
PTEN-null fibroblasts promote increased stem cell activity through decreased JAGGED-1 Given that NOTCH signaling is known to restrict MaSC activity in vivo, 24 we hypothesized that Fsp-cre-mediated ablation of stromal Pten decreases NOTCH signaling in associated MaSC basal/ myoepithelial cells in a non-cell autonomous, paracrine manner. NOTCH3 activation is mediated by JAGGED and DLL ligands. Since these ligands are single-pass transmembrane proteins requiring direct cell-cell contact for ligand-mediated activation of Notch signaling, 25, 26 we postulated that changes in NOTCH3 in the basal/ myoepithelium could be due to decreased ligand expression in adjacent stromal fibroblasts and subsequent autoregulation. To test this possibility, we isolated primary mouse mammary fibroblasts (MMFs) from 8-week-old Pten fl/fl and Fsp-cre;Pten fl/fl animals and evaluated Jag1, Jag2, Dll1, Dll3 and Dll4 mRNA. Importantly, we observed significantly lower Jag1 mRNA expression in PTEN-null MMFs when compared to wild-type MMFs ( Figure 5a ; Supplementary Figure 6A ). Jag2, Dll1 and Dll4 mRNA levels were unchanged, and Dll3 was undetectable by qRT-PCR (Supplementary Figure 6A) . Combined, these results imply that low JAGGED-1 is specifically responsible for the observed phenotype. To further validate these findings, we evaluated Jag1 mRNA in a pair of immortalized wild-type and PTEN-null MMF cells, 16 PTEN mediates stromal-to-epithelial cross-talk through stromal JAGGED-1.
To test whether cross talk from the PTEN-null MMFs alters MaSC activity directly, we isolated Lin − CD24 + CD29 + mammary epithelial cells from ErbB2 mice and cultured these cells on growth arrested wild-type or PTEN-null immortalized MMFs. PTEN-null MMFs greatly enhanced the colony forming ability of purified ErbB2 epithelium confirming a non-cell autonomous role for these fibroblasts in the stem-like capacity of adjacent epithelium (Figure 6a ). To test whether JAGGED-1 downregulation in the PTEN-null MMFs is directly responsible for the increased stem cell activity, we ectopically expressed JAGGED-1 in the PTEN-null MMFs (Supplementary Figure 6C) and found that JAGGED-1 overexpression abrogated the increased epithelial colony forming ability (Figure 6b ). Importantly, NOTCH inhibition via a γ-Secretase inhibitor (GSI-XXI) increases the colony forming capacity of ErbB2 epithelium on wild-type MMFs further supporting a role for low JAGGED-1/NOTCH signaling in associated epithelial stem cell activity (Figure 6c ).
Low expression of stromal JAG1 and stromal PTEN correlates with shorter time to recurrence in breast cancer patients To test the relevance of stromal PTEN-mediated JAGGED-1 signaling in human breast cancer, we evaluated publicly available gene expression data of 53 laser-captured primary breast tumor samples for stromal JAG1 and PTEN expression. 27 Patients were segregated into quartiles depending on stromal expression of JAG1, and survival was compared between patients with high (top 75%) and low (bottom 25%) JAG1. Low stromal JAG1 (Figure 7a ), and similarly, low stromal PTEN (Figure 7b ) correlates with shorter time to recurrence in patients. Importantly, patients with a combination of low stromal PTEN and JAG1 exhibited the shortest time to recurrence when compared to other groups (Figure 7c ) suggesting stromal PTEN acts through JAGGED-1 in suppressing tumor formation.
DISCUSSION
Stromal PTEN regulates mammary gland morphogenesis Stromal fibroblasts maintain the architecture of the mammary gland by regulating ECM deposition, secreting growth factors and facilitating direct mesenchymal-epithelial interactions. 15, 28 It is therefore logical to speculate that genetic alterations within fibroblasts could result in a multitude of disorders, including cancer. Recent evidence suggests that genetic manipulation of stromal cells can transform adjacent epithelium even in the absence of pre-existing hyperplasia. 1, 29, 30 Our own work demonstrates that stromal PTEN loss induces changes in ECM deposition, immune cell infiltration and oncogenic factor secretion, thereby enabling malignant transformation of adjacent pre-neoplastic ErbB2 epithelial cells and accelerating tumor growth. 7, 16 Despite this evidence, how fibroblasts reprogram pre-neoplastic epithelial cells at the earliest stages of breast cancer is poorly understood. In this study, we characterize non-cell autonomous alterations within pre-neoplastic adjacent epithelia in response to stromal loss of PTEN. Specifically, these mice exhibited stunted ductal development and aberrant alveolar side-branching. In the mammary gland, excessive side branching can occur when the cellular microenvironment is disrupted. For example, overexpression of stromal regulators MMP-3 or MMP-14 induces unrestrained aberrant side-branching and consequent tumorigenesis. 31, 32 Our previous findings revealed that loss of stromal PTEN increases MMP9 activity, 7 which could in part explain the restricted ductal elongation and aberrant alveolar side-branching as described herein.
Stromal PTEN regulates the mammary stem cell niche Bipotential MaSCs found in the basal/myoepithelial layer are important in both development and maintenance of mammary homeostasis. 8, 12, 22, 33 Cell fate decisions of stem cells are tightly regulated by extrinsic signals from the niche, which consists of adjacent stromal cells including fibroblasts, growth factors, cytokines and chemokines, and the ECM. 19, 34, 35 Here we report that both wild-type and ErbB2 mice with PTEN-null stroma exhibit an expansion of the CD24 +
CD29
Hi MaSC-enriched population. The altered stem cell activity in vivo was confirmed using well-defined in vitro stem cell assays. It is important to note that we do not see an expansion of MaSC-enriched cells in our ErbB2 animals when compared to syngeneic WT FVB/N controls, which is consistent with previous reports. 22, 23, 33 A significant increase in ErbB2-driven MaSC-enriched basal/myoepithelium occurs only in the context of a PTEN-null stroma. These data corroborate the increase in aberrant alveolar side-branching also seen in these mice implicating stromal PTEN in the regulation of epithelial lineage differentiation through altering the MaSC-enriched pool.
Whether MaSCs from a PTEN-null stromal microenvironment directly alters oncogenic transformation is still unclear. Two independent studies have identified novel CD24 + Jag1
− and CD24 + Sca1 + populations as potential tumor initiating cells in ErbB2-mediated tumorigenesis. 36, 37 Even though the link between these subpopulations and CD24 +
Hi MaSC cells remains undefined, it is likely that the CD24 + Jag1
− and CD24 + Sca1 + populations exist within CD24 + CD29 Hi MaSC-enriched pool and that loss of stromal PTEN similarly alters these tumor initiating subsets. Another possibility is that genetic ablation of fibroblast Pten disrupts paracrine signaling between altered MaSCs and adjacent luminal cells. This disruption would affect proliferation, differentiation and the tumorigenic potential of the luminal cells, which have been postulated to be the cellular precursors for the HER2/ErbB2 luminal subtype of breast cancer. 22, 38 While beyond the scope of the current report, the data reported herein imply that fibroblast PTEN paracrine signaling possibly alters the cell of origin of ErbB2+ breast cancer. 22, 33, 37, 39 Stromal Pten maintains JAGGED-1 and facilitates paracrine NOTCH3-mediated signaling in adjacent mammary epithelium NOTCH receptors, including NOTCH3, are known to be key regulators of stem cell maintenance and differentiation in normal tissue. 25, [40] [41] [42] [43] [44] [45] [46] In the mammary gland specifically, downregulation of NOTCH signaling results in the expansion of MaSCs in vivo, whereas constitutive activation of NOTCH signaling favors luminal cell fate at the expense of basal lineage commitment. 24, 45 These studies revealed that forced NOTCH signaling expands the luminal progenitor population leading to hyperplasia and the highly aggressive basal-like breast cancer. 24, 45 Thus, NOTCH signaling determines alternate outcomes in different mammary cell types in a developmental stage dependent manner. Utilizing genetic mouse models, we show for the first time that mammary glands lacking stromal PTEN exhibit an increase in the MaSC-enriched pool that is attributed to decreased NOTCH signaling within this population corroborating previous findings.
24, 45 Mechanistically, we have identified loss of JAGGED-1 within the PTEN-null mammary fibroblasts as a key mediator of this MaSC niche. Importantly, JAGGED/NOTCH signaling has been well-described to be oncogenic in the breast tumor microenvironment, which may seemingly contradict our findings. [47] [48] [49] [50] [51] [52] However, these previous experiments utilized immortalized breast cancer cell lines to discern the function of stromal JAGGED/NOTCH in promotion of pre-existing tumors. In contrast, our study is quite distinct in that we have focused on the pre-neoplastic MaSC niche to dissect the role of this pathway in normal mammary gland development. Given that low stromal PTEN in combination with low stromal JAG1 is more predictive of earlier breast cancer patient recurrence compared to low stromal expression of either PTEN or JAG1 alone, future studies will focus on defining the association between stromal PTEN and JAGGED-1 in breast cancer.
Combined, we show for the first time that loss of stromal PTEN regulates the pre-neoplastic MaSC niche through 'altered' JAGGED-1 to NOTCH3 paracrine signaling. Based on these results, we propose that at least one of the mechanisms by which stromal PTEN suppresses ErbB2 induced tumor growth is through blocking the expansion of the MaSC-enriched pool. These results highlight a novel role for stromal PTEN in mammary morphogenesis and provide new insights into the complex cross-talk between fibroblasts and the MaSC niche. 
MATERIALS AND METHODS

Transgenic mice
Fsp-cre mice were generated previously and confirmed to express Fsp specifically within the mammary stromal fibroblasts, with absence in the epithelium, macrophages and endothelium. 6, 7 Pten fl/fl mice were created and maintained as reported. 7 MMTV-ErbB2 mice were generously provided by Dr William Muller. 53 All mice were 8-10 weeks of age and at least tenth-generation congenic (N10) FVB/N. Wild-type FVB/N were purchased from Jackson Laboratories (Bar Harbor, ME, USA). Primary mouse MMFs were isolated as described. 54 
Whole-mount analysis
Inguinal mammary glands were harvested as described. 55 Mice in diestrus were excluded. Briefly, ductal length was determined by measuring from the farthest edge of the lymph node (relative to the nipple) to the longest duct. The longest three ducts were averaged per gland and the two inguinal glands averaged per mouse. Alveolar side-branching was determined by counting all aberrant ducts within a representative × 4 field per gland and the two inguinal mammary glands were averaged per mouse.
Fluorescence activated cell sorting
Mammary tissue was harvested as described (4-8 mice/genotype were pooled/experiment). 23 Briefly, tissue was dissociated with a McIlwain tissue chopper (Mickle Laboratory Engineering, Guildford, Surrey, UK) and placed in Epicult-B medium (Stem Cell Technologies, Vancouver, British Columbia, Canada) supplemented with 5% fetal bovine serum, 300 U/ml Collagenase (Sigma, St. Louis, MO, USA) and 100 U/ml hyaluronidase (Sigma), and digested for 1 h at 37°C with gentle shaking. Red blood cells were lysed in ammonium chloride (Stem Cell Technologies). The digested tissue was then sequentially dissociated in 0.25% trypsin-ethylenediaminetetraacetic acid (Sigma) for 1 min, 5 mg/ml Dispase (Stem Cell Technologies) plus 0.1 mg/ml DNase1 (Sigma) for 1 min and filtered through a 40 μm cell strainer. Single cell populations were subjected to a modified negative selection process to obtain lineage negative (Lin − ) subpopulations. In vitro stem/progenitor cell assays MMFs were transiently transfected with empty vector (pENT-CMV4-EF1alpha-GFP) or mouse Jag1 (mJAG1) using jetPEI (Polyplus Transfections, NY, NY, USA), mitomycin C treated on day 2 post-transfection, and epithelia added on day 3 post-transfection. The mJAG1 construct was engineered by Welgen, Inc. (Worcester, MA, USA) PCR amplified mJAG1 (GE Dharmacon MMM1013-202859638; Lafayette, CO, USA) was inserted into pENT-CMVEF1alpha-GFP via EcoR1 and XbaI. Pten fl/fl MMFs were treated with vehicle (dimethylsulphoxide) or GSI-XXI (EMD Millipore, Billerica, MA, USA). After 24 h, the media was replaced with serum-free culture medium as described. 23 Seven to ten days later, colonies were fixed in ice-cold acetone:methanol (1:1), stained with Giemsa and % colony area assessed by a user defined threshold followed by analyzing particles with defined circularity in ImageJ. 57 To assess organoid formation, isolated MaSCenriched cells were suspended in epithelial media (Stem Cell Technologies) with 5% fetal bovine serum and then seeded within 50-μl growth factorreduced matrigel (BD Biosciences) in an eight-well chamber slide at a density of 20 000 cells/well. After 10 days, individual 50-μl matrigel cultures were embedded in histogel (Richard-Allan Scientific, Grand Island, NY, USA) and fixed in 4% paraformaldehyde. These were sectioned and stained with hematoxylin and eosin or processed for immunostaining. For mammosphere assays, single sorted MaSC-enriched cells were plated in ultralow attachment 24-well plates (Corning, Tewksbury, MA, USA) at a density of 10 000 cells/well in serum-free mammary epithelial basal medium (Stem Cell Technologies) plus B27 (Life Technologies, Grand Island, NY, USA), 20 ng/ml EGF (Sigma), 20 ng/ml bFGF (PeproTech, Rocky Hill, NJ, USA) and 4 μg/ml heparin (Sigma) as described. Mammosphere cultures were grown for 14 days and all observable mammospheres counted. 58 Phase contrast imaging and immunostaining All live cell imaging was taken on the EVOS XL Core (Life Technologies). For immunofluorescence, paraffin-embedded tissue and matrigel sections were dewaxed, and subjected to antigen retrieval by steaming samples in DAKO Target retrieval solution (pH 6.1; Carpinteria, CA, USA) for at least 20 mins before blocking with the DAKO antibody diluent. The following primary antibodies were then used: CK8 (#TROMA-1, 1:400, Developmental Studies Hybridoma Bank, Iowa City, IA, USA), CK5 (#ab24647, 1:200, Abcam, Cambridge, MA, USA), α-SMA (#A2547, 1:400, Sigma), JAGGED-1 (#2620, 1:50, Cell Signaling, Danvers, MA, USA) and NOTCH3 (#ab23426, 1:400, Abcam). Secondary detection was performed using antibodies conjugated to AlexaFluor dyes (Invitrogen; Molecular Probes) for 1 h at room temperature. Sections were mounted with SlowFade Gold Antifade mount with DAPI (Life Technologies). Representative fluorescent images were taken on an Eclipse E800 microscope (Nikon Instruments Inc., Melville, NY, USA) using the MetaVue Research Imaging system (Molecular Devices, Sunnyvale, CA, USA) and images for the channels and individually adjusting the threshold for the green (α-SMA) and red (NOTCH3) until only the myoepithelial area staining was visible. The total area of each channel was determined by analyzing particles, and the percentage of red/green calculated. Stromal JAGGED-1 images were quantified using the pattern recognition algorithm in the Inform software (PerkinElmer). Briefly, each image underwent manual tissue segmentation to select only the stroma adjacent to the mammary epithelium for scoring. Other cell types (macrophages, adipocytes, blood vessels) were manually excluded from the stromal area to be scored. The spectrally unmixed Alexafluor-594 signal (JAGGED-1 positivity) was scored Quantitative real-time PCR and immunoblots Total RNA was obtained using TRIzol (Invitrogen), treated with DNAse I (DNA-free, Ambion, Grand Island, NY, USA), and cDNA produced using SuperScript III Reverse Transcriptase (Invitrogen). For cDNA generated from fluorescence activated cell sorting isolated MaSC-enriched, luminal progenitor and mature luminal populations, a pre-amplification step was performed following the TaqMan (Applied Biosystems, Grand Island, NY, USA) PreAmp Master Mix protocol as per the manufacturer's instructions. quantitative real-time PCR was performed using TaqMan Gene Expression Assays and Roche Universal Probe Library primers (listed in Supplementary Methods). Sample quality was verified by comparing C t values for Gapdh. For immunoblotting, fibroblasts were lysed on ice (50 mM Tris-HCl, pH7.4; 100 mM NaCl; 1 mM ethylenediaminetetraacetic acid; 1 mM ethylene-bis(oxyethylenenitrilo)tetraacetic acid; 1 mM sodium fluoride; 0.1% sodium dodecyl sulfate; 0.5% sodium deoxycholate; 1% Triton-X-100; 10% Glycerol; Protease and Phosphatase Inhibitor Cocktails (Sigma)), and protein levels quantified (Bradford Assay, Bio-Rad, Hercules, CA, USA). Protein lysate was resolved using sodium dodecyl sulfate-PAGE, and transferred to polyvinylidene fluoride membrane (EMD Millipore, Billerica, MA, USA). The LiCOR Odyssey TBS Blocking Buffer (Lincoln, NE, USA) was used to block and as a diluent for both primary (Jagged-1-#2620, Cell Signaling; β-actin-#A1978, Sigma) and secondary antibodies (LiCOR). Signal was detected using the LiCOR Odyssey.
Statistical methods
Sample size was not pre-determined statistically. All conclusions were determined by analyzing distinct genetic groups in a blinded fashion. Within each genetic group, mice were randomly utilized. For data of sample sizes 45, normal distribution was determined by Kolmogorov- 
.). (c) Epithelia on Pten
fl/fl MMFs treated with dimethylsulphoxide versus GSI-XXI (n = 2 independent experiments of four mice; bars represent fold change of the total colony area plus s.e.m.; P o0.001 using Student's t-test on biological replicates). Scale bars = 5 mm.
Smirnov Goodness-of-Fit. Sample variance was determined by F-test. Statistical comparison of multiple groups was performed by ANOVA while direct comparison between two groups of normally distributed data was done by homoscedastic or heteroscedastic Student's t-test as appropriate. All analyses using Student's t-test were two-tailed except confirmation by qRT-PCR. For data not normally distributed, statistical comparisons were done by Mann-Whitney. For JAG1 and PTEN related survival analyses, patients in the Finak 27 data set were separated into low (bottom quartile) and high (remaining) expressing groups. Kaplan-Meier survival curves were generated to evaluate survival over a 3-year period. Statistical significance was determined using log-rank. Figure 7 . Low stromal PTEN and low stromal JAG1 correlate with shorter time to recurrence in human breast cancer patients. (a-c) Kaplan-Meier analysis exhibiting recurrence probability for the Finak patient population stratified by low (bottom quartile) versus high (remaining) (a) JAG1 (low, n = 14; high, n = 39), (b) PTEN (low, n = 14; high, n = 39), and (c) combined PTEN and JAG1 (PTEN low/JAG1 low, n = 7; PTEN low/JAG1 high, n = 7; PTEN high/JAG1 low, n = 7; PTEN high/JAG1 high, n = 32) expression. Significance determined by log-rank.
